Spiriva HandiHaler approved for the reduction of COPD exacerbations - MPR
Links shared publicly online about this topic.
- 1,514total visits
Spiriva HandiHaler approved for the reduction of COPD exacerbations - MPR
empr.com —
View full resource at empr.com
Tags: COPD, COPD Medication, Disease and Condition, FDA, Spiriva, Pfizer, Boehringer Ingelheim, Pulmonology
Most Recently Shared on December 21, 2009 at 4:59 pm By:
MPR News: Spiriva HandiHaler approved for the reduction of COPD exacerbations: Spiriva HandiHaler (tiotropium powde... http://bit.ly/6ritCw
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations
drugs.com — “Spiriva HandiHaler (tiotropium bromide) is used for the reduction of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Includes Spiriva HandiHaler side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 20, 2009 at 7:35 pm By:
FDA Approves Spiriva HandiHaler for the Reduction of COPD Exacerbations - http://bit.ly/8NzjMW
Press Releases | Pfizer: the world's largest research-based pharmaceutical company
pfizer.com — “An archive of all Pfizer press releases issued in the United States. Intended as a reference for U.S. investors and journalists.” View full resource at pfizer.com
Most Recently Shared on December 18, 2009 at 2:31 pm By:
FDA approves SPIRIVA® HandiHaler® for the reduction of COPD exacerbations http://bit.ly/5Skobh
Advertisement
